CTRI/2020/05/025022暂停2 期
An open label randomised controlled trial to assess the efficacy of Hydroxychloroquine in patients with mild COVID -19 illness with risk factors for severe disease.
AIIMS Department of Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with RT-PCR confirmed mild COVID-19 illness with high risk factors
- •2.Age > 18 years
- •3.Written informed consent
排除标准
- •1.Patients without any of the high risk factors for severe illness
- •2.Pregnant women
- •3.Known hypersensitivity to HCQ
- •4.Known Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
研究者
相似试验
尚未招募
Unknown
A trial to assess the role of serial physical examination for well appearing babies at risk of sepsisCTRI/2024/04/066566ONE
已完成
不适用
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C and compensated cirrhosis patients with the prescribing pattern of vitaminD plus peginterferon alpha-2a /ribavirin.Chronic hepatitisC patients and compensated cirrhosis patientsJPRN-UMIN000008342Saitama Medical University80
已完成
不适用
An open-label randomized controlled trial to assess the efficacy and safety of chronic hepatitis C patients with vitaminD plus peginterferon alpha-2a /ribavirin.versus alfacalcidol plus peginterferon alpha-2a /ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (>= 5 Log IU/mL)JPRN-UMIN000004210Saitama Medical University40
尚未招募
2 期
To study the effect of Bhunimbadi Vati and its add-on effect with Tablet Glimepiride Metformin in Madhumeha wsr to Type 2 Diabetes mellitusCTRI/2023/03/050496Dr Kiran Damoo Ubhe
招募中
2 期
Effect of cholestyramine on post-ESD ulcer healingJPRN-jRCTs031200235Tamura Shigeki100